Moreover, miR-153 suppresses the AKT signaling pathway in glioblastoma through reduction in expression of insulin receptor substrate-2 (Irs-2) which acts as a molecular adaptor, mediating influences of insulin and insulin-like growth factor 1 (IGF-1) on cell proliferation (Figure 1) (27). The gene discussed is AKT1; the disease is glioblastoma.